CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria
Austria is one of the largest healthcare markets, with a strong focus on pharmaceutical R&D. Austria was ranked sixth globally in terms of healthcare spending (11.1% of GDP). In 2016, the healthcare spending increased to 11.2% of the GDP and per capita spending was $5,227.The value of the Austrian pharmaceutical market value increased from €2.48 billion in 2010 to €2.87 billion in 2017, at a CAGR of 2%.
The aging population, rapid advances in new treatment options, robust healthcare system, high focus on R&D and change in demographics are expected to drive the growth of the pharmaceutical market. However, generic substitution and shortage of specialized staff act as a major barrier for the pharmaceutical market.
On the other hand, Austrian Medical Device market was valued at $1.63 billion in 2010 and increased to $1.95 billion in 2017.The main segments were nephrology and urology devices, orthopedic devices, ophthalmic devices, cardiovascular devices, and in vitro diagnostics. Medical device innovations to provide optimal, quick and affordable patient care in Austria are in the pipeline for years to come.
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Austria, report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Austria. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Austria. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets.
The report provides information on the healthcare, regulatory, and reimbursement landscape in Austria, and includes -
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook